Veterinary Intravenous (IV) Solutions Global Market Report 2025

Description

Veterinary intravenous (IV) solutions are sterile fluids administered directly into an animal's bloodstream through a vein, usually via an IV catheter. These solutions are used in veterinary care to treat dehydration and electrolyte imbalances, deliver medications, or provide essential nutrients. They are crucial for maintaining or restoring fluid and electrolyte balance in animals, particularly during illness, surgery, or trauma.

The main types of veterinary intravenous (IV) solutions include isotonic crystalloids, dextrose solutions, synthetic colloids, natural colloids, and parenteral nutrition. Isotonic crystalloids are IV fluids with a solute concentration equal to that of the blood, helping to maintain fluid balance. These solutions are applicable to various animal types, including companion animals and production animals. They are used by different end-users such as veterinary hospitals and clinics, research institutes, and other related entities.

The veterinary intravenous solutions market research report is one of a series of new reports from The Business Research Company that provides veterinary intravenous solutions market statistics, including veterinary intravenous solutions industry global market size, regional shares, competitors with a veterinary intravenous solutions market share, detailed veterinary intravenous solutions market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary intravenous solutions industry. This veterinary intravenous solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary intravenous (IV) solutions market size has grown strongly in recent years. It will grow from $1.5 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing number of veterinary clinics, rise in incidence of dehydration, growth in livestock farming, rise in the number of companion animals, and growth in veterinary diagnostics.

The veterinary intravenous (IV) solutions market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising adoption of pet insurance, increasing animal healthcare expenditure, growing awareness of animal healthcare, rising incidence of animal diseases, and increasing pet insurance coverage. Major trends in the forecast period include technological advancements, diverse product formulations, telemedicine integration, advanced veterinary intravenous (IV) delivery systems, and smart veterinary intravenous (IV) systems.

The growing prevalence of various animal diseases is anticipated to drive the expansion of the veterinary intravenous (IV) solutions market. Animal diseases are conditions that negatively affect the health and function of animals, with common examples including anthrax, leptospirosis, rabies, canine distemper, and heartworm disease. The rise in these diseases is attributed to factors such as intensive farming practices, wildlife encroachment, and antibiotic resistance. Veterinary IV solutions play a crucial role in rehydrating animals suffering from dehydration caused by illnesses such as gastroenteritis or severe infections, thereby ensuring proper hydration and supporting overall health. For instance, the American Veterinary Medical Association reported in July 2024 that there were 345 confirmed cases of rabies in domestic animals in 2022, a 10.9% increase from the 311 cases in 2021. Thus, the increase in animal diseases is boosting the growth of the veterinary IV solutions market.

Rising expenditure on animal health products is also expected to propel the growth of the veterinary intravenous (IV) solutions market. Animal health products include medications, supplements, and treatments aimed at maintaining or improving animal health. The rise in spending on these products is driven by factors such as increased pet ownership, greater awareness of animal health, advancements in veterinary care, and the need for improved disease prevention and treatment. Veterinary IV solutions contribute to this trend by addressing urgent medical needs and enhancing veterinary care. For example, the Republic of Estonia Agency of Medicines reported in March 2024 that the veterinary medicinal products market grew by 6.9% in 2023, reaching $20.54 million (18.6 million euros), up from $19.21 million (17.40 million euros) in 2022. This increase in spending on animal health products is driving the growth of the veterinary IV solutions market.

Leading companies in the veterinary IV solutions market are focusing on developing advanced products, such as fluoroquinolone antibiotics, to enhance efficacy and safety. Fluoroquinolones are a potent class of antibiotics used in both human and veterinary medicine to treat a variety of bacterial infections, with careful management to prevent resistance and side effects. For example, in April 2024, Elanco, a US-based pharmaceutical company, introduced Pradalex, a pradofloxacin injection solution approved by the US Food and Drug Administration (FDA). This 3rd generation fluoroquinolone is approved for treating swine respiratory disease (SRD) caused by several pathogens, including Bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. The drug's label advises that it should be used only after other non-fluoroquinolone treatment options have been considered.

Major companies operating in the veterinary intravenous (IV) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Sante Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd

North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary intravenous (IV) solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary intravenous (IV) solutions market consists of sales of hypertonic solutions, isotonic solutions, and hypertonic solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Intravenous (IV) Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary intravenous (iv) solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary intravenous (iv) solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary intravenous (iv) solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Isotonic Crystalloids; Dextrose Solutions; Synthetic Colloids; Natural Colloids; Parenteral Nutrition
2) By Animal Type: Companion Animals; Production Animals
3) By End-User: Veterinary Hospitals And Clinics; Research Institutes; Other End-Users
Subsegments:
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl); Lactated Ringer's Solution; Dextrose in Water (D5W); Ringer's Solution; Balanced Electrolyte Solutions
2) Dextrose Solutions: Dextrose 5% in Water (D5W); Dextrose 10% in Water (D10W); Dextrose 20% in Water (D20W); Dextrose 50% in Water (D50W)
3) Synthetic Colloids: Hydroxyethyl Starch (HES); Dextran; Gelatins
4) Natural Colloids: Albumin; Fresh Frozen Plasma (FFP); Blood Products
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions; Partial Parenteral Nutrition Solutions; Lipid Emulsions; Amino Acid Solutions
Companies Mentioned: Merck & Co. Inc.; Baxter International Inc.; Zoetis Inc.; Fresenius Kabi AG; Elanco Animal Health Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33616

1. Executive Summary

2. Veterinary Intravenous (IV) Solutions Market Characteristics

3. Veterinary Intravenous (IV) Solutions Market Trends And Strategies

4. Veterinary Intravenous (IV) Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Intravenous (IV) Solutions Growth Analysis And Strategic Analysis Framework

5.1. Global Veterinary Intravenous (IV) Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Veterinary Intravenous (IV) Solutions Market Growth Rate Analysis
5.4. Global Veterinary Intravenous (IV) Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Veterinary Intravenous (IV) Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Veterinary Intravenous (IV) Solutions Total Addressable Market (TAM)

6. Veterinary Intravenous (IV) Solutions Market Segmentation

6.1. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Isotonic Crystalloids
Dextrose Solutions
Synthetic Colloids
Natural Colloids
Parenteral Nutrition
6.2. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Companion Animals
Production Animals
6.3. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals And Clinics
Research Institutes
Other End-Users
6.4. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Isotonic Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Normal Saline (0.9% NaCl)
Lactated Ringer's Solution
Dextrose in Water (D5W)
Ringer's Solution
Balanced Electrolyte Solutions
6.5. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Dextrose Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dextrose 5% in Water (D5W)
Dextrose 10% in Water (D10W)
Dextrose 20% in Water (D20W)
Dextrose 50% in Water (D50W)
6.6. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Synthetic Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hydroxyethyl Starch (HES)
Dextran
Gelatins
6.7. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Natural Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Albumin
Fresh Frozen Plasma (FFP)
Blood Products
6.8. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Parenteral Nutrition, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Total Parenteral Nutrition (TPN) Solutions
Partial Parenteral Nutrition Solutions
Lipid Emulsions
Amino Acid Solutions

7. Veterinary Intravenous (IV) Solutions Market Regional And Country Analysis

7.1. Global Veterinary Intravenous (IV) Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Veterinary Intravenous (IV) Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Intravenous (IV) Solutions Market

8.1. Asia-Pacific Veterinary Intravenous (IV) Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Intravenous (IV) Solutions Market

9.1. China Veterinary Intravenous (IV) Solutions Market Overview
9.2. China Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Intravenous (IV) Solutions Market

10.1. India Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Intravenous (IV) Solutions Market

11.1. Japan Veterinary Intravenous (IV) Solutions Market Overview
11.2. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Intravenous (IV) Solutions Market

12.1. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Intravenous (IV) Solutions Market

13.1. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Intravenous (IV) Solutions Market

14.1. South Korea Veterinary Intravenous (IV) Solutions Market Overview
14.2. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Intravenous (IV) Solutions Market

15.1. Western Europe Veterinary Intravenous (IV) Solutions Market Overview
15.2. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Intravenous (IV) Solutions Market

16.1. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Intravenous (IV) Solutions Market

17.1. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Intravenous (IV) Solutions Market

18.1. France Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Intravenous (IV) Solutions Market

19.1. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Intravenous (IV) Solutions Market

20.1. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Intravenous (IV) Solutions Market

21.1. Eastern Europe Veterinary Intravenous (IV) Solutions Market Overview
21.2. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Intravenous (IV) Solutions Market

22.1. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Intravenous (IV) Solutions Market

23.1. North America Veterinary Intravenous (IV) Solutions Market Overview
23.2. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Intravenous (IV) Solutions Market

24.1. USA Veterinary Intravenous (IV) Solutions Market Overview
24.2. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Intravenous (IV) Solutions Market

25.1. Canada Veterinary Intravenous (IV) Solutions Market Overview
25.2. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Intravenous (IV) Solutions Market

26.1. South America Veterinary Intravenous (IV) Solutions Market Overview
26.2. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Intravenous (IV) Solutions Market

27.1. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Intravenous (IV) Solutions Market

28.1. Middle East Veterinary Intravenous (IV) Solutions Market Overview
28.2. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Intravenous (IV) Solutions Market

29.1. Africa Veterinary Intravenous (IV) Solutions Market Overview
29.2. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Intravenous (IV) Solutions Market Competitive Landscape And Company Profiles

30.1. Veterinary Intravenous (IV) Solutions Market Competitive Landscape
30.2. Veterinary Intravenous (IV) Solutions Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Intravenous (IV) Solutions Market Other Major And Innovative Companies

31.1. B. Braun Melsungen AG
31.2. Virbac SA
31.3. Dechra Pharmaceuticals PLC
31.4. Vetoquinol SA
31.5. Norbrook Laboratories Limited
31.6. Ceva Sante Animale
31.7. Revival Animal Health Inc.
31.8. Aromor Animal Health
31.9. Jorgensen Laboratories LLC
31.10. Pharmacosmos AS
31.11. Sykes Veterinary International Pty Ltd.
31.12. Rusoma Laboratories Private Limited
31.13. Patterson Companies Inc.
31.14. NexGen Veterinary
31.15. Soxa Formulations & Research Pvt.Ltd

32. Global Veterinary Intravenous (IV) Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Intravenous (IV) Solutions Market

34. Recent Developments In The Veterinary Intravenous (IV) Solutions Market

35. Veterinary Intravenous (IV) Solutions Market High Potential Countries, Segments and Strategies

35.1 Veterinary Intravenous (IV) Solutions Market In 2029 - Countries Offering Most New Opportunities
35.2 Veterinary Intravenous (IV) Solutions Market In 2029 - Segments Offering Most New Opportunities
35.3 Veterinary Intravenous (IV) Solutions Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33616_Veterinary_Intravenous_IV_Solutions_GMR_2025